definiens: statements as that term is defined in the Private SecuritiesLitigation Reform Act of 1995 regarding, among other things, statements relating to goals, plans, objectives and futureevents . Theravance Biopharma intends such forward - looking statements to be covered by the safe harbor provisionsfor forward - looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the PrivateSecurities Litigation Reform Act of 1995 . Examples of such statements include statements relating to : the Company’sstrategies, plans and objectives, the Company ’s regulatory strategies and timing and results of clinical studies, thepotential benefits and mechanisms of action of the Company ’s product and product candidates and the Company’sexpectations for product candidates through development and commercialization . These statements are based on thecurrent estimates and assumptions of the management of Theravance Biopharma as of the date of the press releaseand are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause theactual results of Theravance Biopharma to be materially different from those reflected in the forward - lookingstatements . Important factors that could cause actual results to differ materially from those indicated by such forward - looking statements include, among others, risks related to : delays or difficulties in commencing or completing clinicalstudies, the potential that results from clinical or non - clinical studies indicate the Company ’s product candidates areunsafe or ineffective, the feasibility of undertaking future clinical trials for our product candidates based on FDApolicies and feedback, dependence on third parties to conduct clinical studies, delays or failure to achieve andmaintain regulatory approvals for product candidates . Other risks affecting Theravance Biopharma are describedunder the heading contained in Theravance Biopharma ’s Quarterly Report on Form 10 - Q filed with the ® ® ® Securities and Exchange Commission ( SEC ) on May 10, 2016 . In addition to the risks described above and inTheravance Biopharma ’s other filings with the SEC, other unknown or unpredictable factors also could affectTheravance Biopharma ’s results . No forward - looking statements can be guaranteed and actual results may differmaterially from such statements . Given these uncertainties, you should not place undue reliance on these forward - looking statements . Theravance Biopharma assumes no obligation to update its forward - looking statements onaccount of new information, future events or otherwise, except as required by law